Contact Us

- Request a Quote
- Order spare parts
- Learn about PureNano
- Proof of Concept
- Talk to Sales

Latest News & Events

News - Vaccine Adjuvant Webinar - Feb 2 2012

PICKERING EMULSIONS – SUPPORTING THE WORLD OF LIQUID-LIQUID DISPERSIONS

Nutraceutical Webinar - Sept 29, 2011

> View Archives
hero2
Microfluidizer® high shear fluid processors are the gold standard in nano-enabled applications for uniform particle size reduction, cell disruption and bottom-up nanoparticle creation – with scaleup guaranteed. Discover why 17 of the top 20 global pharmaceutical companies innovate with Microfluidics technology.
get a quote

Thank you to all who completed our survey! A donation has been made for each of you to St. Jude Children's Research Hospital.

Biphasic Vesicles: A Novel, Lipid-Based, Dermal Delivery System for Large-Molecule Drugs

Although challenging, success with biphasic vesicles offers the potential of needle-free administration of many pharmaceuticals, including biologics, that medical practitioners until now could administer only by injection. Research scientists envision biphasic vesicles as a way to deliver existing drugs in the developmental stage that previously had been shelved due to severe delivery issues. At the same time, biphasic vesicles enable the design of difficult-to-deliver molecules for a broad range of new drugs, allowing noninvasive and safe delivery through the skin.  Learn more about utilizing Microfluidizer processors in this month's issue of TransDermal Journal.transdermal

Microfluidics and Quadro Engineering to Present Webinar on Vaccine and Vaccine Adjuvant Development

Complimentary Event Offers Innovative High Shear Technologies for Scalable, Faster, Reliable and Efficient Development

Learn about technologies that enable faster, more highly reliable and more efficient development of vaccines and vaccine adjuvants for widespread distribution.

Microfluidics and Quadro Engineering present a free webinar demonstrating how micron, submicron and nanoparticle size reductions -- achieved using innovative, single pass, high shear energy technology -- can improve vaccine-related emulsions, nanoemulsion, nanosuspensions, slurries and cell disruption while reducing capital investment, manufacturing and maintenance costs.

Entrepreneur uses M-110Y Microfluidizer to develop algae for biofuel 

Fox News interviews Dean Tsoupeis about his method for creating environmentally friendly, renewable energy from algae farms. See the story here.

       
                

PureNanoTM Continuous Crystallizer

Download a new white paper detailing PureNano Contintuous Crystallization for innovative pharma applications - featuring a cancer drug case study.